Ingevity Corp
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
NGVT$60.78-2.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Years Ended December 31, | |||
|---|---|---|---|
| In millions, except per share data | 2023 | 2022 | 2021 |
| Net sales | $1,692.1 | $1,668.3 | $1,391.5 |
| Cost of sales | 1,220.2 | 1,098.2 | 878.7 |
| Gross profit | 471.9 | 570.1 | 512.8 |
| Selling, general, and administrative expenses | 183.7 | 198.8 | 179.3 |
| Research and technical expenses | 31.8 | 30.3 | 26.3 |
| Restructuring and other (income) charges, net | 170.2 | 13.8 | 16.2 |
| Acquisition-related costs | 3.6 | 5.0 | 0.6 |
| Other (income) expense, net | 5.7 | (1.7) | 79.9 |
| Interest expense | 93.3 | 61.8 | 51.7 |
| Interest income | (6.3) | (7.5) | (4.0) |
| Income (loss) before income taxes | (10.1) | 269.6 | 162.8 |
| Provision (benefit) for income taxes | (4.7) | 58.0 | 44.7 |
| Net income (loss) | $(5.4) | $211.6 | $118.1 |
| Per share data | |||
| Basic earnings (loss) per share | $(0.15) | $5.54 | $2.97 |
| Diluted earnings (loss) per share | (0.15) | 5.50 | 2.95 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.